Multiple Sclerosis Clinical Trials in Long Beach, CA

16 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis	Phase 3	Novartis Pharmaceuticals	17 mi
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis	Phase 3	Zenas BioPharma (USA), LLC	17 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)	—	TG Therapeutics, Inc.	19 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease	—	TScan Therapeutics, Inc.	20 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab	Phase 3	TG Therapeutics, Inc.	20 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study	Phase 2	Darcy Krueger	20 mi
TSC Biosample Repository and Natural History Database	—	National Tuberous Sclerosis Association	20 mi
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis	Phase 2	Novartis Pharmaceuticals	20 mi
MS-ResearchBiomarkerS	—	Cedars-Sinai Medical Center	20 mi
Study of COYA 302 for the Treatment of ALS	Phase 2	Coya Therapeutics	20 mi
Central Vein Sign in Multiple Sclerosis Extension Study	N/A	The Cleveland Clinic	20 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.	Phase 3	Novartis Pharmaceuticals	22 mi
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study	N/A	SetPoint Medical Corporation	22 mi
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis	Phase 3	Zenas BioPharma (USA), LLC	24 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis	Phase 3	Sanofi	24 mi
Entire-body PET Scans for Multiple Sclerosis	Early 1	Brain Health Alliance	35 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.